Overview

Phase 2 Study of EPI-743 in Children With Pearson Syndrome

Status:
Terminated
Trial end date:
2016-02-29
Target enrollment:
Participant gender:
Summary
Treatment of Pediatric Subjects with Pearson syndrome
Phase:
Phase 2
Details
Lead Sponsor:
Edison Pharmaceuticals Inc
Treatments:
Ubiquinone